Frequency of Hypocalcemia among Patients with Moderate to Severe Chronic Plaque Psoriasis
Chronic Plaque Psoriasis
DOI:
https://doi.org/10.54393/pjhs.v4i11.1061Keywords:
Chronic Plaque, Psoriasis, Severity, HypocalcemiaAbstract
Psoriasis is a common skin problem. It is associated with many risk factors including hypocalcemia. It is important to determine serum calcium levels among psoriatic patients that may help in proper management. Objective: To determine frequency of hypocalcemia in patients of moderate to severe chronic plaque psoriasis. Methods: It was a cross-sectional study that had involved 90 patients of both genders aged between 22-70 years having chronic plaque psoriasis. The patients were evaluated for level of calcium in serum and hypocalcemia was labeled if albumin corrected serum calcium was <8.9 mg/dl. A prior written informed consent was taken from each patient. Results: The mean age of the patients was 40.7 ±1 3.9 years. There were 51 (56.7%) male and 39 (43.3%) female patients with a male to female ratio of 1.3:1. The mean duration of disease was 9.2 ± 4.4 years while the mean serum calcium was 8.89 ± 0.79 mg/dl. 59 (65.6%) patients had moderate while 31 (34.4%) patients had severe disease. Hypocalcemia was observed in 35 (38.9%) patients and it was significantly higher in patients with severe disease as compared to moderate disease (58.1% vs. 28.8%; p-value=0.007). Conclusions: In this study a substantial proportion of patients with chronic plaque psoriasis had hypocalcemia suggesting potential role of serum calcium in the pathogenesis of psoriasis. Hypocalcemia may also indicate severity of disease. This study advocates routine screening a correction of serum calcium levels among such patients as it leads to timely identification and appropriate management of the disease.
References
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020 May; 369: m1590. doi: 10.1136/bmj.m1590. DOI: https://doi.org/10.1136/bmj.m1590
Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clinical Medicine (Lond). 2021 May; 21(3): 170-3. doi: 10.7861/clinmed.2021-0257. DOI: https://doi.org/10.7861/clinmed.2021-0257
Albanesi C, Madonna S, Gisondi P, Girolomoni G. The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis. Frontiers in Immunology. 2018 Jul; 9: 1549. doi: 10.3389/fimmu.2018.01549. DOI: https://doi.org/10.3389/fimmu.2018.01549
Qadim H, Goforousha F, Nejad S, Goldust M. Studying the Calcium Serum Level in Patients Suffering from Psoriasis. Pakistan Journal of Biological Sciences. 2013 Mar; 16(6): 291-4. doi: 10.3923/pjbs.2013.291.294. DOI: https://doi.org/10.3923/pjbs.2013.291.294
Maheswari A and Dutta B. Correlation of hypocalcaemia with severity and type of psoriasis: A cross-sectional study. Indian Journal of Clinical and Experimental Dermatology. 2021 May; 7(2): 164-8. doi: 10.18231/j.ijced.2021.031. DOI: https://doi.org/10.18231/j.ijced.2021.031
Tampa M, Sarbu MI, Mitran MI, Mitran CI, Matei C, Georgescu SR. The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease. Disease Markers. 2018 Jan; 2018: 5823684. doi: 10.1155/2018/5823684. DOI: https://doi.org/10.1155/2018/5823684
Ingrasciotta Y, Isgrò V, Ientile V, Tari M, Trifirò G, Guarneri C. Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy. Journal of Clinical Medicine. 2021 Jul; 10(15): 3431. doi: 10.3390/jcm10153431. DOI: https://doi.org/10.3390/jcm10153431
Jomah NS, Ismaiel MA, Khadam J. Evaluation of serum Calcium level in psoriatic patients. Journal of Medical and Pharmaceutical Sciences. 2022 Jun; 6(3): 40-51. doi: 10.26389/AJSRP.R051121. DOI: https://doi.org/10.26389/AJSRP.R051121
Mohamad SN. Trace elements homeostatic imbalance in mild and severe psoriasis: a new insight in biomarker diagnostic value for psoriasis. Our Dermatology Online. 2013 Oct; 4(4): 449-52. doi: 10.7241/ourd.20134.115. DOI: https://doi.org/10.7241/ourd.20134.115
Häbel H, Wettermark B, Hägg D, Villacorta R, Wennerström ECM, Linder M. Societal impact for patients with psoriasis: A nationwide Swedish register study. JAAD International. 2021 Jun; 3: 63-75. doi: 10.1016/j.jdin.2021.02.003. DOI: https://doi.org/10.1016/j.jdin.2021.02.003
Haider S, Wahid Z, Najam-us-Saher, Riaz F. Efficacy of methotrexate in patients with plaque type psoriasis. Pakistan Journal of Medical Sciences. 2014 Sep; 30(5): 1050-3. doi: 10.12669/pjms.305.4451. DOI: https://doi.org/10.12669/pjms.305.4451
Rawat L, Kothiwala R, Mehra A. India. Serum calcium level in patients suffering from psoriasis and its correlation with severity of psoriasis: A case control study. International Multispecialty Journal of Health (IMJH). 2019: 2395-6291.
Chaudhari S and Rathi S. Correlation of serum calcium levels with severity of psoriasis. International Journal of Research in Dermatology. 2018 Nov; 4(4): 591-4. doi: 10.18203/issn.2455-4529.IntJResDermatol20184467. DOI: https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20184467
Das S, Biswas UK, Kumar A, Roy A. Study of serum carbonic anhydrase activity, uric acid, C-reactive protein levels and lipid parameters in patients with Psoriasis. Nepal Journal of Dermatology Venereology & Leprology. 2013 April; 11(1): 20-7. doi: 10.3126/njdvl.v11i1.7931. DOI: https://doi.org/10.3126/njdvl.v11i1.7931
Shaiq PA, Stuart PE, Latif A, Schmotzer C, Kazmi AH, Khan MS, et al. Genetic associations of psoriasis in a Pakistani population. British Journal of Dermatology. 2013 Aug; 169(2): 406-11. doi: 10.1111/bjd.12313. DOI: https://doi.org/10.1111/bjd.12313
Asim SA, Hameed A, Niaz F, Sarwat A. To assess the frequency of raised serum uric acid level in patients with psoriasis and compare it with healthy controls in outpatient of a tertiary care hospital. International Journal of Advance Research. 2016 June; 4(6): 2124-32. doi: 10.21474/IJAR01/728. DOI: https://doi.org/10.21474/IJAR01/728
Bijina KD, Raghavendra BN, Mohamed M. A study of serum calcium and uric acid levels in psoriasis. Indian Journal of Clinical and Experimental Dermatology. 2018 Dec; 4(4): 342-5. doi: 10.18231/2581-4729.2018.0075. DOI: https://doi.org/10.18231/2581-4729.2018.0075
Choi JW, Kim BR, Seo E, Youn SW. Identification of nail features associated with psoriasis severity. Journal of Dermatology. 2017 Feb; 44(2): 147-53. doi: 10.1111/1346-8138.13565. DOI: https://doi.org/10.1111/1346-8138.13565
Anuja GE and Sarojini PA. Psoriatic arthropathy: a clinical and biochemical study. Indian Journal of Dermatology Venereology & Leprology. 1997 Dec; 63(6): 357-60.
Basha MA, Shehta WA, Gayed IM, EI Hagary SB. The value of calcium and high sensitivity Creactive protein serum levels in psoriatic patients. Monoufia Medical Journal. 2021 Mar; 34: 56-60. doi: 10.4103/mmj.mmj_227_19. DOI: https://doi.org/10.4103/mmj.mmj_227_19
Zhai Z, Chen L, Yang H, Yan J, Wang C, Yang J, et al. Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis. Journal of American Academy of Dermatology. 2015 Dec; 73(6): 991-7. doi: 10.1016/j.jaad.2015.08.036. DOI: https://doi.org/10.1016/j.jaad.2015.08.036
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments